Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Treatment | 124 |
| Prevention | 13 |
| Diagnostic | 10 |
| Basic Science | 3 |
| Other | 3 |
| Supportive Care | 2 |
| Health Services Research | 1 |
| Screening | 1 |
| NA | 1 |
Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG
To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html
| Type | Study_count |
|---|---|
| Total_Studies | 269 |
| interventional | 158 |
| Observational | 99 |
| Registry | 12 |
```
| intervention_type | Study_Count |
|---|---|
| Drug | 84 |
| Drug|placebo | 22 |
| Biological | 14 |
| Other | 9 |
| Procedure | 8 |
| Device | 5 |
| Behavioral | 3 |
| Biological|Drug | 3 |
| Diagnostic Test | 3 |
| Device|Drug | 2 |
| Drug|Other | 2 |
| Device|Other | 1 |
| Drug|placebo|Procedure | 1 |
| Genetic | 1 |
| Country | Study_Count |
|---|---|
| United States | 25 |
| France | 11 |
| NA | 8 |
| United Kingdom | 8 |
| Brazil | 6 |
| Canada | 5 |
| Japan | 5 |
| Germany | 4 |
| China | 3 |
| Spain | 3 |
| India | 2 |
| Israel | 2 |
| Korea, Republic of | 2 |
| United States|Israel|United Kingdom | 2 |
| Australia | 1 |
| Australia|Austria|Belgium|Canada|Denmark|Finland|Germany|Italy|Netherlands|Norway|Singapore|Spain|Sweden|Switzerland|United Kingdom | 1 |
| Australia|Austria|Canada|France|Germany|Israel|Singapore|South Africa|United Kingdom | 1 |
| Australia|Belgium|Canada|Denmark|France|Germany|Ireland|Italy|Netherlands|Spain|United Kingdom | 1 |
| Australia|Canada|France|Germany|Spain|Sweden|United Kingdom | 1 |
| Australia|Denmark|Finland|Germany|Italy|Singapore|Spain|Taiwan|United Kingdom | 1 |
| Australia|New Zealand | 1 |
| Austria|Belgium|China|Germany|Hong Kong|Italy|Netherlands|Portugal|Singapore|Spain|Switzerland|Taiwan|United Kingdom | 1 |
| Austria|Czech Republic|Denmark|Finland|France|Germany|Hong Kong|Italy|Poland|Spain|Taiwan|United Kingdom | 1 |
| Austria|Denmark|Germany|Italy|Malaysia|South Africa|Spain|Sweden|Switzerland|Thailand|United Kingdom | 1 |
| Belgium|Germany|Poland|Spain|Switzerland | 1 |
| Bulgaria|United States|Belarus|Romania|Russian Federation|Ukraine | 1 |
| Canada|Finland|Germany|India|Israel|Italy|Netherlands|Singapore|Spain|Switzerland|Taiwan | 1 |
| China|Taiwan|Thailand | 1 |
| Denmark | 1 |
| Denmark|Germany|Netherlands|Norway|United Kingdom | 1 |
| Egypt | 1 |
| Finland | 1 |
| France|Germany|Israel | 1 |
| France|Hungary|Israel|Poland|Spain|Turkey|United Kingdom | 1 |
| France|South Africa|United Kingdom | 1 |
| Germany|Greece|Italy|Spain|United Kingdom | 1 |
| Germany|Israel|Italy|Spain|Switzerland | 1 |
| Germany|Japan|Spain | 1 |
| Germany|Latvia|Malaysia|Spain | 1 |
| Japan|United States|Australia|Brazil|Canada|Croatia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Lithuania|Malaysia|Netherlands|Norway|Portugal|Puerto Rico|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom | 1 |
| Lithuania | 1 |
| Malaysia|Philippines|Thailand | 1 |
| Malaysia|United Kingdom | 1 |
| Netherlands | 1 |
| Portugal | 1 |
| Singapore|United States|Canada|Italy | 1 |
| Spain|Sweden|United States|Austria|Canada|Croatia|Denmark|Greece|Israel|Italy|Japan|Malaysia|Ukraine|United Kingdom | 1 |
| Sweden | 1 |
| Switzerland | 1 |
| Turkey | 1 |
| United States|Algeria|Argentina|Australia|Austria|Bulgaria|Canada|France|Germany|Greece|Israel|Italy|Japan|Malaysia|Romania|Spain|Taiwan|Thailand | 1 |
| United States|Algeria|Argentina|Australia|Austria|Canada|France|Germany|Israel|Italy|Japan|Malaysia|Netherlands|Spain|Taiwan|Thailand|United Kingdom | 1 |
| United States|Algeria|Austria|Brazil|China|Denmark|Greece|Hong Kong|Hungary|Japan|Lithuania|Poland|Portugal|Puerto Rico|Russian Federation|Serbia|Spain|Turkey | 1 |
| United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Croatia|Czechia|Finland|France|Germany|Hungary|India|Israel|Korea, Republic of|Netherlands|New Zealand|Peru|Russian Federation|Serbia|Spain|Taiwan|United Kingdom | 1 |
| United States|Argentina|Austria|Croatia|Denmark|Germany|Hong Kong|India|Indonesia|Israel|Italy|Norway|Pakistan|Poland|Serbia|South Africa|Spain|Sweden|Taiwan|Thailand|Turkey|United Kingdom | 1 |
| United States|Argentina|Brazil|Bulgaria|France|Philippines|Poland|Romania|Russian Federation|South Africa|Spain|Turkey | 1 |
| United States|Argentina|Brazil|Canada|Croatia|France|Hungary|Israel|Italy|Japan|Malaysia|Poland|South Africa|Spain|Taiwan|Thailand|Turkey|United Kingdom | 1 |
| United States|Australia|Austria|Belgium|Brazil|Canada|China|Croatia|Denmark|Finland|France|Germany|Hong Kong|Israel|Italy|Netherlands|Norway|Singapore|Spain|Sweden|Switzerland|Taiwan|Thailand | 1 |
| United States|Australia|Austria|Croatia|France|Germany|Israel|Malaysia|Netherlands|Poland|Spain|Thailand|Turkey|Ukraine|United Kingdom | 1 |
| United States|Australia|Austria|Denmark|Finland|France|Germany|Israel|Italy|Poland|Singapore|Spain|Sweden|Switzerland|Thailand|United Kingdom | 1 |
| United States|Australia|Brazil|Bulgaria|Croatia|Denmark|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Malaysia|Netherlands|Norway|Puerto Rico|Russian Federation|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom | 1 |
| United States|Australia|Brazil|Bulgaria|Croatia|Denmark|France|Germany|Hungary|Israel|Italy|Japan|Malaysia|Netherlands|Norway|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom | 1 |
| United States|Austria|Brazil|Croatia|Greece|Hungary|Italy|Japan|Malaysia|Poland|Puerto Rico|Romania|Russian Federation|Serbia|South Africa|Taiwan|Thailand|Turkey|United Kingdom | 1 |
| United States|Austria|Bulgaria|Germany|Serbia|Spain|Taiwan | 1 |
| United States|Austria|Canada|Finland|France|Germany|Israel|Italy|Japan|Spain|Switzerland|United Kingdom | 1 |
| United States|Austria|Canada|Finland|France|Germany|Israel|Italy|Spain|Switzerland|United Kingdom | 1 |
| United States|Austria|France|Germany|Greece|Italy|Japan|Macedonia, The Former Yugoslav Republic of|Malaysia|Netherlands|Romania|Russian Federation|South Africa|Spain|Taiwan|Thailand|Turkey|United Kingdom | 1 |
| United States|Austria|France|Germany|Greece|Italy|Japan|Macedonia, The Former Yugoslav Republic of|Malaysia|Netherlands|Romania|South Africa|Spain|Taiwan|Thailand|Turkey|United Kingdom | 1 |
| United States|Austria|France|Germany|Japan|Serbia | 1 |
| United States|Belarus|Bulgaria|Lebanon|Romania|Russian Federation | 1 |
| United States|Brazil|Canada|Croatia|France|Germany|Italy|Japan|Malaysia|Taiwan|United Kingdom | 1 |
| United States|Brazil|Canada|France|Greece|Israel|Italy|Japan|Lithuania|Malaysia|Portugal|Puerto Rico|Switzerland|Turkey|Ukraine|United Kingdom | 1 |
| United States|Brazil|Croatia|Denmark|Former Serbia and Montenegro|Germany|Hungary|Israel|Italy|Japan|Malaysia|Russian Federation|Serbia|Spain|Switzerland|Taiwan|Turkey|United Kingdom | 1 |
| United States|Brazil|Croatia|Germany|Israel|Italy|Japan|Latvia|Lithuania|Macedonia, The Former Yugoslav Republic of|Malaysia|Poland|Puerto Rico|Russian Federation|Serbia|Spain|Switzerland|Taiwan|Turkey|United Kingdom | 1 |
| United States|Brazil|Former Serbia and Montenegro|France|Japan|Malaysia|Serbia|South Africa|Sweden|Turkey|United Kingdom | 1 |
| United States|Brazil|Italy|Japan|Lithuania|Macedonia, The Former Yugoslav Republic of|Malaysia|Poland|Puerto Rico|Russian Federation|Serbia|Taiwan|Turkey | 1 |
| United States|Canada | 1 |
| United States|Canada|Denmark|Germany|Israel|Italy|Japan|Spain|Sweden|United Kingdom | 1 |
| United States|Canada|Denmark|Germany|United Kingdom | 1 |
| United States|Canada|France|Germany|Hungary|Italy|Japan|Macedonia, The Former Yugoslav Republic of|Malaysia|Netherlands|Russian Federation|South Africa|Thailand|Turkey|United Kingdom | 1 |
| United States|Denmark|France|Germany|Japan|Spain|Sweden|United Kingdom | 1 |
| United States|Denmark|France|Germany|Netherlands|Spain | 1 |
| United States|Denmark|France|United Kingdom | 1 |
| United States|Germany|Italy|Japan|Switzerland|Turkey|United Kingdom | 1 |
| United States|Germany|Switzerland | 1 |
| United States|Greece|Japan|Malaysia|Romania|Serbia|Thailand | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 71 |
| 2 | 5 |
| 3 | 5 |
| 4 | 4 |
| 5 | 2 |
| 6 | 2 |
| 7 | 5 |
| 8 | 2 |
| 9 | 3 |
| 10 | 2 |
| 11 | 2 |
| 12 | 1 |
| 13 | 2 |
| 14 | 3 |
| 15 | 6 |
| 16 | 1 |
| 18 | 4 |
| 19 | 2 |
| 20 | 1 |
| 22 | 2 |
| 24 | 1 |
| 25 | 1 |
| 30 | 1 |
| 32 | 2 |
| 33 | 1 |
| 34 | 2 |
| 35 | 1 |
| 37 | 2 |
| 38 | 1 |
| 41 | 1 |
| 43 | 1 |
| 44 | 1 |
| 45 | 1 |
| 46 | 1 |
| 49 | 1 |
| 51 | 1 |
| 52 | 1 |
| 57 | 1 |
| 59 | 1 |
| 61 | 1 |
| 63 | 1 |
| 64 | 1 |
| 66 | 1 |
| 69 | 2 |
| 70 | 2 |
| 93 | 1 |
| 161 | 1 |
| 167 | 1 |
| Phase | Study_Count |
|---|---|
| Phase 3 | 37 |
| Phase 1 | 35 |
| N/A | 31 |
| Phase 2 | 26 |
| Phase 4 | 20 |
| Phase 1/Phase 2 | 7 |
| Phase 2/Phase 3 | 2 |
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 39 |
| 2 | 80 |
| 3 | 13 |
| 4 | 6 |
| 5 | 1 |
| 6 | 1 |
| 11 | 1 |
| NA | 17 |
| Measure | N.A | Phase.1 | Phase.1.Phase.2 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|---|
| Min. | 4.0000 | 4.0 | 10.00000 | 4.0000 | 40.0 | 6.0000 | 15.0 |
| 1st Qu. | 46.5000 | 15.0 | 25.00000 | 31.0000 | 67.5 | 57.5000 | 31.5 |
| Median | 80.0000 | 24.0 | 50.00000 | 60.0000 | 95.0 | 74.0000 | 44.0 |
| Mean | 182.4516 | 31.4 | 48.28571 | 124.8077 | 95.0 | 201.0833 | 139.9 |
| 3rd Qu. | 108.0000 | 38.5 | 60.00000 | 186.5000 | 122.5 | 189.5000 | 155.0 |
| Max. | 1098.0000 | 160.0 | 108.00000 | 479.0000 | 150.0 | 1316.0000 | 1006.0 |
| group_type | Group_Count |
|---|---|
| Experimental | 189 |
| Active Comparator | 50 |
| Placebo Comparator | 29 |
| NA | 17 |
| No Intervention | 10 |
| Other | 6 |
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 89 |
| Single Group Assignment | 49 |
| Crossover Assignment | 15 |
| Sequential Assignment | 3 |
| Factorial Assignment | 1 |
| NA | 1 |
| primary_purpose | Study_Count |
|---|---|
| Treatment | 124 |
| Prevention | 13 |
| Diagnostic | 10 |
| Basic Science | 3 |
| Other | 3 |
| Supportive Care | 2 |
| Health Services Research | 1 |
| Screening | 1 |
| NA | 1 |
| Country | Study_Count |
|---|---|
| United States | 23 |
| Japan | 7 |
| Switzerland | 6 |
| France | 5 |
| NA | 5 |
| Germany | 4 |
| China | 3 |
| Czechia | 3 |
| Korea, Republic of | 3 |
| Belgium | 2 |
| Brazil | 2 |
| Greece | 2 |
| India | 2 |
| Italy | 2 |
| Spain | 2 |
| Turkey | 2 |
| United States|Canada | 2 |
| Algeria|Austria|Belgium|Czech Republic|France|Germany|Italy|Netherlands|Poland|Portugal|Saudi Arabia|South Africa|Sweden|Turkey|United Kingdom|Venezuela | 1 |
| Algeria|Morocco|Oman|Saudi Arabia|United Arab Emirates | 1 |
| Argentina|Austria|Belgium|France|Germany|Hungary|Iran, Islamic Republic of|Ireland|Italy|Poland|Portugal|Slovakia|Sweden|United Kingdom | 1 |
| Austria | 1 |
| Canada|Spain|United Kingdom | 1 |
| Croatia|Czechia|Estonia|Germany|Greece|Israel|Spain|Sweden | 1 |
| Denmark | 1 |
| Finland | 1 |
| Hungary | 1 |
| India|Morocco|Oman|South Africa | 1 |
| Israel | 1 |
| Mexico | 1 |
| Mexico|Venezuela | 1 |
| Netherlands | 1 |
| Slovakia | 1 |
| Thailand | 1 |
| United Kingdom | 1 |
| United States|Algeria|Austria|Belgium|Bulgaria|France|Germany|Hungary|Italy|Netherlands|Pakistan|Spain|Sweden|Switzerland|United Kingdom | 1 |
| United States|Argentina|Canada|Croatia|Czech Republic|France|Germany|Ireland|Italy|Slovakia|Spain|Sweden|Switzerland|United Kingdom | 1 |
| United States|Australia|Canada|Thailand | 1 |
| United States|Austria|Czechia|France|Germany|Greece|Hungary|Italy|Netherlands|Poland|Slovakia|Slovenia|Spain|Sweden|Switzerland | 1 |
| United States|Canada|Germany|United Kingdom | 1 |
| United States|Canada|Hungary|Italy|Spain|United Kingdom | 1 |
| United States|France|Germany|Greece|Hong Kong|India|Iran, Islamic Republic of|Israel|Italy|Pakistan|Serbia|Slovakia|Spain|Thailand|Turkey|Venezuela | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 74 |
| 2 | 5 |
| 3 | 3 |
| 4 | 2 |
| 5 | 1 |
| 7 | 2 |
| 9 | 1 |
| 10 | 1 |
| 11 | 1 |
| 14 | 2 |
| 15 | 1 |
| 16 | 2 |
| 17 | 1 |
| 35 | 1 |
| 41 | 1 |
| 61 | 1 |
| Measure | Observational |
|---|---|
| Min | 2.0000 |
| 1st Qu | 38.0000 |
| Median | 86.0000 |
| Mean | 641.6392 |
| 3rd Qu | 300.0000 |
| Max | 19200.0000 |
| observational_model | Study_Count |
|---|---|
| Cohort | 62 |
| Case-Only | 9 |
| Other | 9 |
| NA | 9 |
| Case-Control | 8 |
| Case Control | 1 |
| Ecologic or Community | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 70 |
| Retrospective | 12 |
| Cross-Sectional | 10 |
| NA | 7 |
| Country | Study_Count |
|---|---|
| Italy | 4 |
| United States | 4 |
| Spain | 2 |
| NA | 1 |
| Switzerland | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 10 |
| 2 | 1 |
| 20 | 1 |
| Measure | Registries |
|---|---|
| Min | 40.000 |
| 1st Qu | 75.000 |
| Median | 200.000 |
| Mean | 1058.833 |
| 3rd Qu | 1104.000 |
| Max | 5000.000 |
| observational_model | Study_Count |
|---|---|
| Cohort | 6 |
| Case-Control | 3 |
| Case-Only | 1 |
| Ecologic or Community | 1 |
| Other | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 8 |
| Cross-Sectional | 2 |
| Other | 2 |
| target_duration | Study_Count |
|---|---|
| 1 Day | 2 |
| 10 Years | 2 |
| 2 Years | 2 |
| 5 Years | 2 |
| 3 Days | 1 |
| 3 Years | 1 |
| 30 Days | 1 |
| 5 Months | 1 |
#If less then 500 trials
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT03821597 | Sequential Compression Devices Effect on Fibrinolysis in Plastic Surgery Outpatients | https://ClinicalTrials.gov/show/NCT03821597 | Completed | Swanson Center | 2018-12-31 |
| NCT03355742 | XIENCE 28 Global Study | https://ClinicalTrials.gov/show/NCT03355742 | Completed | Abbott Medical Devices | 2019-10-24 |
| NCT03304977 | Patient’s Knowledge on Their Anticoagulating and Anti Platelet Treatment St Joseph’s Hospital) | https://ClinicalTrials.gov/show/NCT03304977 | Completed | Groupe Hospitalier Paris Saint Joseph | 2016-07-31 |
| NCT03296033 | Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin | https://ClinicalTrials.gov/show/NCT03296033 | Recruiting | Wake Forest University Health Sciences | 2022-06-30 |
| NCT03196284 | A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors | https://ClinicalTrials.gov/show/NCT03196284 | Completed | Novo Nordisk A/S | 2018-09-19 |
| NCT03075670 | A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B | https://ClinicalTrials.gov/show/NCT03075670 | Completed | Novo Nordisk A/S | 2017-12-08 |
| NCT03011827 | Thromboelastometry in Liver Transplantation | https://ClinicalTrials.gov/show/NCT03011827 | Recruiting | Hospital Clinic of Barcelona | 2022-09-30 |
| NCT02994407 | Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A | https://ClinicalTrials.gov/show/NCT02994407 | Completed | Novo Nordisk A/S | 2018-10-15 |
| NCT02979158 | Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass | https://ClinicalTrials.gov/show/NCT02979158 | Completed | Umeå University | 2018-01-24 |
| NCT02972684 | Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass | https://ClinicalTrials.gov/show/NCT02972684 | Completed | Nantes University Hospital | 2020-02-29 |
| NCT02941354 | Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A | https://ClinicalTrials.gov/show/NCT02941354 | Completed | Novo Nordisk A/S | 2017-06-20 |
| NCT02920398 | A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A | https://ClinicalTrials.gov/show/NCT02920398 | Completed | Novo Nordisk A/S | 2017-04-07 |
| NCT02918045 | Dental Extractions in Patients Under Dual Antiplatelet Therapy | https://ClinicalTrials.gov/show/NCT02918045 | Completed | University of Sao Paulo General Hospital | 2019-07-16 |
| NCT02864875 | Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibility Trial | https://ClinicalTrials.gov/show/NCT02864875 | Completed | University of Sao Paulo General Hospital | 2017-01-31 |
| NCT02834130 | Input of a Multidisciplinary Device to Accompany the Announce of Diagnosis for Young Children With Serious Constitutional Hemorrhagic Disease and Their Families | https://ClinicalTrials.gov/show/NCT02834130 | Completed | Assistance Publique Hopitaux De Marseille | 2016-04-30 |
| NCT02777424 | CPP Versus PFC to Correct Coagulation Disorders in Adult Neurosurgical Patients | https://ClinicalTrials.gov/show/NCT02777424 | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 2021-07-21 |
| NCT02750150 | Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients | https://ClinicalTrials.gov/show/NCT02750150 | Completed | University Hospital, Lille | 2016-01-31 |
| NCT02736812 | Pre-hospital Administration of Lyophilized Plasma for Post-traumatic Coagulopathy Treatment (PREHO-PLYO) | https://ClinicalTrials.gov/show/NCT02736812 | Completed | French Defence Health Service | 2019-10-31 |
| NCT02689232 | TEG (Thromboelastography) Based Versus Conventional Coagulation Parameters Based Correction of Coagulopathy in Non Variceal Bleed. | https://ClinicalTrials.gov/show/NCT02689232 | Completed | Institute of Liver and Biliary Sciences, India | 2018-03-03 |
| NCT02637427 | Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures | https://ClinicalTrials.gov/show/NCT02637427 | Recruiting | Rutgers, The State University of New Jersey | 2020-04-30 |
| NCT02622126 | Colloid Pre-Loading on D-Dimer During Cesarean Section Under Spinal Anesthesia | https://ClinicalTrials.gov/show/NCT02622126 | Completed | Assiut University | 2016-07-31 |
| NCT02601053 | The Fear F8ctor Study - Does Fear Induce a Blood Curdling State? | https://ClinicalTrials.gov/show/NCT02601053 | Completed | Leiden University Medical Center | 2015-08-31 |
| NCT02593877 | Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy | https://ClinicalTrials.gov/show/NCT02593877 | Completed | Queen Mary University of London | 2018-07-03 |
| NCT02541942 | Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adeptâ„¢2 Trial | https://ClinicalTrials.gov/show/NCT02541942 | Completed | Novo Nordisk A/S | 2016-04-15 |
| NCT02490787 | Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects | https://ClinicalTrials.gov/show/NCT02490787 | Completed | Novo Nordisk A/S | 2016-10-14 |
| NCT02457403 | Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy: Rotational Thromboelastometry Versus Conventional Therapy | https://ClinicalTrials.gov/show/NCT02457403 | Completed | Ohio State University | 2018-11-30 |
| NCT02362178 | Thromboelastographic Guide for Blood Products in Cirrhotics | https://ClinicalTrials.gov/show/NCT02362178 | Completed | University of Modena and Reggio Emilia | 2014-08-31 |
| NCT02352181 | Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment. | https://ClinicalTrials.gov/show/NCT02352181 | Completed | Hospices Civils de Lyon | 2016-08-31 |
| NCT02281201 | Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects | https://ClinicalTrials.gov/show/NCT02281201 | Completed | CSL Behring | 2016-01-31 |
| NCT02239146 | Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass | https://ClinicalTrials.gov/show/NCT02239146 | Completed | Novo Nordisk A/S | 2008-01-31 |
| NCT02238028 | Short-term Cardiovascular Benefits of Wearing Particulate-filtering Respirators | https://ClinicalTrials.gov/show/NCT02238028 | Completed | Fudan University | 2014-10-31 |
| NCT02203968 | Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST) | https://ClinicalTrials.gov/show/NCT02203968 | Completed | Sunnybrook Health Sciences Centre | 2015-12-31 |
| NCT02187120 | Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study) | https://ClinicalTrials.gov/show/NCT02187120 | Recruiting | Monash University | 2021-01-31 |
| NCT02141074 | Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B | https://ClinicalTrials.gov/show/NCT02141074 | Recruiting | Novo Nordisk A/S | 2022-10-30 |
| NCT02120300 | Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders | https://ClinicalTrials.gov/show/NCT02120300 | Completed | Gilead Sciences | 2015-08-31 |
| NCT02096523 | Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder | https://ClinicalTrials.gov/show/NCT02096523 | Enrolling by invitation | Hadassah Medical Organization | 2021-05-31 |
| NCT01288391 | Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients | https://ClinicalTrials.gov/show/NCT01288391 | Completed | Novo Nordisk A/S | 2011-07-31 |
| NCT01272206 | Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects | https://ClinicalTrials.gov/show/NCT01272206 | Completed | Novo Nordisk A/S | 2011-03-31 |
| NCT02009033 | Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery | https://ClinicalTrials.gov/show/NCT02009033 | Completed | Rigshospitalet, Denmark | 2013-04-30 |
| NCT01916408 | The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon | https://ClinicalTrials.gov/show/NCT01916408 | Completed | Technische Universität München | 2014-01-31 |
| NCT01848002 | Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT01848002 | Completed | Novo Nordisk A/S | 2003-08-31 |
| NCT01847989 | Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT01847989 | Completed | Novo Nordisk A/S | 2003-05-31 |
| NCT01787552 | A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF | https://ClinicalTrials.gov/show/NCT01787552 | Completed | Novartis | 2018-04-10 |
| NCT01752725 | Comparison of BiCision® Versus UltraCision® During Laparoscopic Supracervical Hysterectomy (LASH) | https://ClinicalTrials.gov/show/NCT01752725 | Completed | University Hospital Tuebingen | 2012-04-30 |
| NCT01731600 | A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A | https://ClinicalTrials.gov/show/NCT01731600 | Completed | Novo Nordisk A/S | 2014-09-15 |
| NCT01692925 | Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A | https://ClinicalTrials.gov/show/NCT01692925 | Completed | Novo Nordisk A/S | 2013-03-31 |
| NCT01601613 | Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever | https://ClinicalTrials.gov/show/NCT01601613 | Completed | Novo Nordisk A/S | 2002-11-30 |
| NCT01601457 | Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture Reconstruction | https://ClinicalTrials.gov/show/NCT01601457 | Completed | Novo Nordisk A/S | 2004-04-30 |
| NCT01598831 | Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy | https://ClinicalTrials.gov/show/NCT01598831 | Completed | Asahi Kasei Pharma America Corporation | 2018-04-05 |
| NCT01590823 | An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients | https://ClinicalTrials.gov/show/NCT01590823 | Completed | Nova Scotia Health Authority | 2012-09-30 |
| NCT01589666 | Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT01589666 | Completed | Entegrion, Inc. | 2016-09-09 |
| NCT01588132 | Anfibatide Phase 1 Clinical Trial in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT01588132 | Completed | Lee’s Pharmaceutical Limited | 2011-03-31 |
| NCT01566786 | Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage | https://ClinicalTrials.gov/show/NCT01566786 | Completed | Novo Nordisk A/S | 2002-10-31 |
| NCT01563523 | Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients | https://ClinicalTrials.gov/show/NCT01563523 | Completed | Novo Nordisk A/S | 2003-10-31 |
| NCT01563471 | Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT01563471 | Completed | Novo Nordisk A/S | 2002-07-31 |
| NCT01563458 | Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation | https://ClinicalTrials.gov/show/NCT01563458 | Completed | Novo Nordisk A/S | 2003-08-31 |
| NCT01563445 | Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage | https://ClinicalTrials.gov/show/NCT01563445 | Completed | Novo Nordisk A/S | 2003-03-31 |
| NCT01562821 | Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy | https://ClinicalTrials.gov/show/NCT01562821 | Completed | Novo Nordisk A/S | 2002-12-31 |
| NCT01562587 | Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State | https://ClinicalTrials.gov/show/NCT01562587 | Completed | Novo Nordisk A/S | 2003-05-31 |
| NCT01562574 | Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease | https://ClinicalTrials.gov/show/NCT01562574 | Completed | Novo Nordisk A/S | 2004-08-31 |
| NCT01562158 | Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation | https://ClinicalTrials.gov/show/NCT01562158 | Completed | Novo Nordisk A/S | 2003-10-31 |
| NCT01561924 | Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography | https://ClinicalTrials.gov/show/NCT01561924 | Completed | Novo Nordisk A/S | 2006-05-31 |
| NCT01561417 | Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects | https://ClinicalTrials.gov/show/NCT01561417 | Completed | Novo Nordisk A/S | 2006-09-30 |
| NCT01561391 | Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery | https://ClinicalTrials.gov/show/NCT01561391 | Completed | Novo Nordisk A/S | 2004-05-31 |
| NCT01555749 | Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects | https://ClinicalTrials.gov/show/NCT01555749 | Completed | Novo Nordisk A/S | 2012-05-08 |
| NCT01536496 | Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma | https://ClinicalTrials.gov/show/NCT01536496 | Completed | Denver Health and Hospital Authority | 2014-04-30 |
| NCT01493778 | Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A | https://ClinicalTrials.gov/show/NCT01493778 | Completed | Novo Nordisk A/S | 2017-08-16 |
| NCT01487837 | Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study. | https://ClinicalTrials.gov/show/NCT01487837 | Completed | University Children’s Hospital, Zurich | 2014-10-31 |
| NCT01480180 | Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A | https://ClinicalTrials.gov/show/NCT01480180 | Completed | Novo Nordisk A/S | 2018-12-10 |
| NCT01467427 | Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B. | https://ClinicalTrials.gov/show/NCT01467427 | Active, not recruiting | Novo Nordisk A/S | 2014-03-30 |
| NCT01435304 | The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass | https://ClinicalTrials.gov/show/NCT01435304 | Completed | Maine Medical Center | 2014-12-31 |
| NCT01395810 | Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773 | https://ClinicalTrials.gov/show/NCT01395810 | Completed | Novo Nordisk A/S | 2014-03-30 |
| NCT01392547 | Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors | https://ClinicalTrials.gov/show/NCT01392547 | Completed | Novo Nordisk A/S | 2012-08-31 |
| NCT01386528 | Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B | https://ClinicalTrials.gov/show/NCT01386528 | Completed | Novo Nordisk A/S | 2013-12-01 |
| NCT01365520 | A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A | https://ClinicalTrials.gov/show/NCT01365520 | Completed | Novo Nordisk A/S | 2011-09-30 |
| NCT01333111 | Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients | https://ClinicalTrials.gov/show/NCT01333111 | Completed | Novo Nordisk A/S | 2013-03-31 |
| NCT04444700 | A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04444700 | Recruiting | University of Sao Paulo General Hospital | 2020-10-31 |
| NCT04362085 | Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care | https://ClinicalTrials.gov/show/NCT04362085 | Recruiting | St. Michael’s Hospital, Toronto | 2020-11-30 |
| NCT04360824 | Covid-19 Associated Coagulopathy | https://ClinicalTrials.gov/show/NCT04360824 | Recruiting | University of Iowa | 2021-04-16 |
| NCT04309084 | Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma | https://ClinicalTrials.gov/show/NCT04309084 | Recruiting | Celularity Incorporated | 2023-03-12 |
| NCT04188171 | Sclerotherapy With Polidocanol Foam In The Treatment Of Hemorrhoidal Disease In Patients With Bleeding Disorders | https://ClinicalTrials.gov/show/NCT04188171 | Recruiting | Universidade do Porto | 2020-02-01 |
| NCT04140812 | Stratifying Risk for Intracerebral Haemorrhage | https://ClinicalTrials.gov/show/NCT04140812 | Recruiting | University of Erlangen-Nürnberg Medical School | 2020-09-30 |
| NCT04121767 | Safety and Efficacy of Edoxaban in Thoracoscopic Ablation | https://ClinicalTrials.gov/show/NCT04121767 | Recruiting | Samsung Medical Center | 2020-06-30 |
| NCT04074980 | Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test | https://ClinicalTrials.gov/show/NCT04074980 | Completed | LumiraDx UK Limited | 2019-07-30 |
| NCT04046029 | Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention. | https://ClinicalTrials.gov/show/NCT04046029 | Recruiting | The First Affiliated Hospital of Dalian Medical University | 2020-07-30 |
| NCT03815175 | XIENCE 28 USA Study | https://ClinicalTrials.gov/show/NCT03815175 | Active, not recruiting | Abbott Medical Devices | 2020-12-31 |
| NCT03756948 | Viscoelastic Tests-Guided Therapy In Liver Transplantation | https://ClinicalTrials.gov/show/NCT03756948 | Completed | Hospital Israelita Albert Einstein | 2015-10-30 |
| NCT03734588 | Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors | https://ClinicalTrials.gov/show/NCT03734588 | Active, not recruiting | Spark Therapeutics | 2020-05-31 |
| NCT03700723 | Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy | https://ClinicalTrials.gov/show/NCT03700723 | Active, not recruiting | Entegrion, Inc. | 2020-12-31 |
| NCT03666650 | NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT03666650 | Completed | Turku University Hospital | 2019-01-08 |
| NCT03616808 | Thromboelastometry-identified Haemostatic Changes in Isolated Traumatic Brain Injury | https://ClinicalTrials.gov/show/NCT03616808 | Recruiting | Lithuanian University of Health Sciences | 2020-08-30 |
| NCT03570281 | Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study) | https://ClinicalTrials.gov/show/NCT03570281 | Recruiting | Samsung Medical Center | 2020-05-31 |
| NCT03520712 | Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5 | https://ClinicalTrials.gov/show/NCT03520712 | Enrolling by invitation | BioMarin Pharmaceutical | 2025-06-30 |
| NCT03449342 | Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period | https://ClinicalTrials.gov/show/NCT03449342 | Completed | Novo Nordisk A/S | 2019-03-25 |
| NCT03444324 | Adjusted Fibrinogen Replacement Strategy | https://ClinicalTrials.gov/show/NCT03444324 | Recruiting | Biotest | 2020-01-31 |
| NCT01253811 | Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency | https://ClinicalTrials.gov/show/NCT01253811 | Completed | Novo Nordisk A/S | 2015-03-31 |
| NCT01238367 | A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543 | https://ClinicalTrials.gov/show/NCT01238367 | Completed | Novo Nordisk A/S | 2011-10-31 |
| NCT01230021 | Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit Deficiency | https://ClinicalTrials.gov/show/NCT01230021 | Completed | Novo Nordisk A/S | 2012-01-31 |
| NCT01228669 | Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B | https://ClinicalTrials.gov/show/NCT01228669 | Completed | Novo Nordisk A/S | 2012-09-10 |
| NCT01205724 | Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A | https://ClinicalTrials.gov/show/NCT01205724 | Completed | Novo Nordisk A/S | 2011-04-30 |
| NCT01187225 | Fibrinogen Concentrate In Children After Cardiac Surgery | https://ClinicalTrials.gov/show/NCT01187225 | Completed | University of Sao Paulo | 2011-01-31 |
| NCT01153997 | Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers | https://ClinicalTrials.gov/show/NCT01153997 | Completed | Novo Nordisk A/S | 2010-08-31 |
| NCT01138501 | Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A | https://ClinicalTrials.gov/show/NCT01138501 | Completed | Novo Nordisk A/S | 2011-11-30 |
| NCT01082406 | Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects | https://ClinicalTrials.gov/show/NCT01082406 | Completed | Novo Nordisk A/S | 2010-07-31 |
| NCT03871452 | The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding | https://ClinicalTrials.gov/show/NCT03871452 | Completed | Haydarpasa Numune Training and Research Hospital | 2018-10-11 |
| NCT01029340 | Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A | https://ClinicalTrials.gov/show/NCT01029340 | Completed | Bayer | 2012-06-30 |
| NCT00994045 | Fibrinogen as an Alternative to FFP in Aortic Surgery. | https://ClinicalTrials.gov/show/NCT00994045 | Completed | University of Edinburgh | 2013-08-31 |
| NCT00984126 | Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015 | https://ClinicalTrials.gov/show/NCT00984126 | Completed | Novo Nordisk A/S | 2016-06-28 |
| NCT00978380 | Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725 | https://ClinicalTrials.gov/show/NCT00978380 | Completed | Novo Nordisk A/S | 2015-10-20 |
| NCT00966290 | Anticoagulant Clinics and Vitamin K Antagonists | https://ClinicalTrials.gov/show/NCT00966290 | Completed | University Hospital, Toulouse | 2006-12-31 |
| NCT00956345 | Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B | https://ClinicalTrials.gov/show/NCT00956345 | Completed | Novo Nordisk A/S | 2010-07-31 |
| NCT00951873 | A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers | https://ClinicalTrials.gov/show/NCT00951873 | Completed | Novo Nordisk A/S | 2010-04-30 |
| NCT00951405 | Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors | https://ClinicalTrials.gov/show/NCT00951405 | Completed | Novo Nordisk A/S | 2011-03-29 |
| NCT00945542 | The Trauma- Formula-Driven Versus Lab-Guided Study (TRFL Study) | https://ClinicalTrials.gov/show/NCT00945542 | Completed | Sunnybrook Health Sciences Centre | 2011-12-31 |
| NCT00964353 | Clinical and Economic Implications of Genetic Testing for Warfarin Management | https://ClinicalTrials.gov/show/NCT00964353 | Completed | University of Chicago | 2012-08-31 |
| NCT00922792 | Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B | https://ClinicalTrials.gov/show/NCT00922792 | Completed | Novo Nordisk A/S | 2009-09-30 |
| NCT00914589 | Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery | https://ClinicalTrials.gov/show/NCT00914589 | Completed | Novo Nordisk A/S | 2011-02-28 |
| NCT00904709 | The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders | https://ClinicalTrials.gov/show/NCT00904709 | Completed | Nova Scotia Health Authority | 2014-03-01 |
| NCT00868309 | A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab, | https://ClinicalTrials.gov/show/NCT00868309 | Completed | Instituto Bioclon S.A. de C.V. | 2006-08-31 |
| NCT00840086 | Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects | https://ClinicalTrials.gov/show/NCT00840086 | Completed | Novo Nordisk A/S | 2011-09-30 |
| NCT02938585 | Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A | https://ClinicalTrials.gov/show/NCT02938585 | Completed | Novo Nordisk A/S | 2018-03-16 |
| NCT01143909 | Transfusion of Fresh Frozen Plasma in Non-bleeding Intensive Care Unit (ICU) Patients | https://ClinicalTrials.gov/show/NCT01143909 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2013-06-30 |
| NCT00837356 | Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects | https://ClinicalTrials.gov/show/NCT00837356 | Completed | Novo Nordisk A/S | 2009-10-31 |
| NCT00822185 | Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT00822185 | Completed | Novo Nordisk A/S | 2009-07-31 |
| NCT03826043 | THrombo-Embolic Event in Onco-hematology | https://ClinicalTrials.gov/show/NCT03826043 | Recruiting | Centre Antoine Lacassagne | 2022-03-08 |
| NCT03232398 | Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus | https://ClinicalTrials.gov/show/NCT03232398 | Recruiting | Hadassah Medical Organization | 2020-07-31 |
| NCT01949792 | A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors | https://ClinicalTrials.gov/show/NCT01949792 | Completed | Novo Nordisk A/S | 2013-11-30 |
| NCT00816127 | Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction | https://ClinicalTrials.gov/show/NCT00816127 | Completed | Icahn School of Medicine at Mount Sinai | 2007-05-31 |
| NCT01562457 | Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State | https://ClinicalTrials.gov/show/NCT01562457 | Completed | Novo Nordisk A/S | 2006-04-30 |
| NCT01489111 | Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A. | https://ClinicalTrials.gov/show/NCT01489111 | Completed | Novo Nordisk A/S | 2018-12-10 |
| NCT02137850 | Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A | https://ClinicalTrials.gov/show/NCT02137850 | Enrolling by invitation | Novo Nordisk A/S | 2021-11-13 |
| NCT02822599 | Human Fibrinogen Concentrate in Pediatric Cardiac Surgery | https://ClinicalTrials.gov/show/NCT02822599 | Completed | Nicklaus Children’s Hospital f/k/a Miami Children’s Hospital | 2019-08-26 |
| NCT03528551 | A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A | https://ClinicalTrials.gov/show/NCT03528551 | Active, not recruiting | Novo Nordisk A/S | 2020-12-03 |
| NCT03884725 | Fibrinogen Concentrate In Children Cardiac Surgery 2 | https://ClinicalTrials.gov/show/NCT03884725 | Recruiting | Instituto do Coracao | 2019-06-30 |
| NCT00803101 | An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure | https://ClinicalTrials.gov/show/NCT00803101 | Completed | CSL Behring | 2012-11-30 |
| NCT00713648 | Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency | https://ClinicalTrials.gov/show/NCT00713648 | Completed | Novo Nordisk A/S | 2010-04-30 |
| NCT00708435 | Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy | https://ClinicalTrials.gov/show/NCT00708435 | Completed | CSL Behring | 2010-11-30 |
| NCT00697385 | The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders | https://ClinicalTrials.gov/show/NCT00697385 | Completed | Mary M. Gooley Hemophilia Center | 2008-06-30 |
| NCT00571584 | High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors | https://ClinicalTrials.gov/show/NCT00571584 | Completed | Novo Nordisk A/S | 2004-03-31 |
| NCT00493272 | Dilutional Coagulopathy in Patients Undergoing Elective Surgery | https://ClinicalTrials.gov/show/NCT00493272 | Completed | University of Aarhus | 2008-04-30 |
| NCT00486278 | Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds | https://ClinicalTrials.gov/show/NCT00486278 | Completed | Novo Nordisk A/S | 2010-06-30 |
| NCT00426803 | Recombinant Factor VIIa in Acute Intracerebral Haemorrhage | https://ClinicalTrials.gov/show/NCT00426803 | Completed | Novo Nordisk A/S | 2004-06-30 |
| NCT00355290 | Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial | https://ClinicalTrials.gov/show/NCT00355290 | Completed | Hospital de Clinicas de Porto Alegre | NA |
| NCT00266006 | Factor VIIa in Acute Intracerebral Haemorrhage | https://ClinicalTrials.gov/show/NCT00266006 | Completed | Novo Nordisk A/S | 2007-04-30 |
| NCT00212485 | Study to Evaluate the Use of Ultrasound in the Diagnosis of Hemophilic Joint Disease | https://ClinicalTrials.gov/show/NCT00212485 | Completed | New York Presbyterian Hospital | 2008-04-30 |
| NCT00188747 | Comparison of Three Management Strategies for Post Cardiac Surgery Bleeding | https://ClinicalTrials.gov/show/NCT00188747 | Completed | University Health Network, Toronto | NA |
| NCT00168090 | Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) | https://ClinicalTrials.gov/show/NCT00168090 | Completed | CSL Behring | NA |
| NCT00154492 | Use of NovoSeven® in Active Variceal Bleeding | https://ClinicalTrials.gov/show/NCT00154492 | Completed | Novo Nordisk A/S | 2006-08-31 |
| NCT00143715 | Oral Vitamin K for Warfarin Associated Coagulopathy | https://ClinicalTrials.gov/show/NCT00143715 | Completed | St. Joseph’s Healthcare Hamilton | 2006-10-31 |
| NCT00127283 | Recombinant Factor VIIa in Acute Intracerebral Haemorrhage | https://ClinicalTrials.gov/show/NCT00127283 | Completed | Novo Nordisk A/S | 2007-01-31 |
| NCT00123591 | Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury | https://ClinicalTrials.gov/show/NCT00123591 | Completed | Novo Nordisk A/S | 2006-05-31 |
| NCT00111215 | Treatment and Management of Women With Bleeding Disorders | https://ClinicalTrials.gov/show/NCT00111215 | Completed | Centers for Disease Control and Prevention | NA |
| NCT00108797 | Trial of NovoSeven® in Haemophilia - Joint Bleeds | https://ClinicalTrials.gov/show/NCT00108797 | Completed | Novo Nordisk A/S | 2006-02-28 |
| NCT00108758 | Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia | https://ClinicalTrials.gov/show/NCT00108758 | Completed | Novo Nordisk A/S | 2005-11-30 |
| NCT00104455 | Dose Response to Recombinant Factor VIIa When Administered for Bleed | https://ClinicalTrials.gov/show/NCT00104455 | Completed | Novo Nordisk A/S | 2004-11-30 |
| NCT00102037 | Use of Activated Recombinant FVII in Spinal Surgery | https://ClinicalTrials.gov/show/NCT00102037 | Completed | Novo Nordisk A/S | 2006-02-28 |
| NCT00056589 | Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency | https://ClinicalTrials.gov/show/NCT00056589 | Completed | Novo Nordisk A/S | 2003-10-31 |
| NCT00000582 | Cooperative Study of Factor VIII Inhibitors | https://ClinicalTrials.gov/show/NCT00000582 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | NA |
#If less then 500 studies
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT04278404 | Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | https://ClinicalTrials.gov/show/NCT04278404 | Recruiting | Duke University | 2024-04-24 |
| NCT03871283 | Anticoagulation and Antiplatelet Management During Perioperative Period | https://ClinicalTrials.gov/show/NCT03871283 | Recruiting | Erasme University Hospital | 2019-12-31 |
| NCT03292666 | Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study | https://ClinicalTrials.gov/show/NCT03292666 | Recruiting | University of California, San Francisco | 2020-12-31 |
| NCT03280368 | Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT03280368 | Completed | Hospitalsenheden Vest | 2019-11-30 |
| NCT03275077 | To Compare TEG (Thrombelastography) and Conventional Tests in CKD Patients | https://ClinicalTrials.gov/show/NCT03275077 | Completed | Institute of Liver and Biliary Sciences, India | 2016-12-22 |
| NCT03267823 | INR Comparison Testing in Cardiac Surgery | https://ClinicalTrials.gov/show/NCT03267823 | Completed | University of Miami | 2019-03-21 |
| NCT03195543 | Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension | https://ClinicalTrials.gov/show/NCT03195543 | Recruiting | National and Kapodistrian University of Athens | 2020-12-31 |
| NCT03179748 | Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients | https://ClinicalTrials.gov/show/NCT03179748 | Enrolling by invitation | Novo Nordisk A/S | 2021-06-28 |
| NCT03168087 | Plasmalyte-148 Solution and Blood Coagulation | https://ClinicalTrials.gov/show/NCT03168087 | Completed | Seoul National University Hospital | 2018-08-23 |
| NCT03128658 | Trauma Induced Coagulopathy and Inflammation | https://ClinicalTrials.gov/show/NCT03128658 | Recruiting | University of Pennsylvania | 2020-12-31 |
| NCT03112525 | DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic | https://ClinicalTrials.gov/show/NCT03112525 | Recruiting | University Hospital, Geneva | 2020-04-30 |
| NCT03105180 | Irrigating Fluid and Blood Coagulation | https://ClinicalTrials.gov/show/NCT03105180 | Completed | Seoul National University Bundang Hospital | 2017-03-29 |
| NCT02991066 | Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia | https://ClinicalTrials.gov/show/NCT02991066 | Recruiting | First Affiliated Hospital of Harbin Medical University | 2019-12-31 |
| NCT02884999 | Management of Bleeding and Coagulopathy in Trauma and Compliance to European Trauma Guidelines | https://ClinicalTrials.gov/show/NCT02884999 | Completed | University Hospital, Brest | 2015-11-30 |
| NCT02856789 | Determination of Fibrin Activity in Plasma on STA-R® Prototype | https://ClinicalTrials.gov/show/NCT02856789 | Recruiting | Diagnostica Stago R&D | 2019-03-31 |
| NCT02670213 | A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan | https://ClinicalTrials.gov/show/NCT02670213 | Enrolling by invitation | Novo Nordisk A/S | 2024-09-30 |
| NCT02652897 | Hemostasis Alterations in Neurosurgical Patients | https://ClinicalTrials.gov/show/NCT02652897 | Recruiting | Hospitales Universitarios Virgen del RocÃo | 2019-02-28 |
| NCT02035384 | Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A | https://ClinicalTrials.gov/show/NCT02035384 | Completed | Novo Nordisk A/S | 2020-01-15 |
| NCT02540005 | Coagulation Disorders After Aneurysmatic Subarachnoid Haemorrhage | https://ClinicalTrials.gov/show/NCT02540005 | Completed | Tampere University Hospital | 2016-06-30 |
| NCT02422810 | High-Shear Microfluidic Thrombosis Assay | https://ClinicalTrials.gov/show/NCT02422810 | Completed | Emory University | 2015-10-31 |
| NCT02387944 | Bedside Evaluation of Coagulation in Children With Congenital Heart Disease | https://ClinicalTrials.gov/show/NCT02387944 | Completed | Centre Hospitalier Universitaire Vaudois | 2017-07-06 |
| NCT02352805 | Coagulopathy and SIRS During ECC in Intensive Care | https://ClinicalTrials.gov/show/NCT02352805 | Active, not recruiting | University Hospital Tuebingen | 2020-12-31 |
| NCT02329899 | Standardisation of Investigations of Mild Bleeding Disorders | https://ClinicalTrials.gov/show/NCT02329899 | Completed | University Hospital, Geneva | 2016-09-30 |
| NCT02241694 | To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives | https://ClinicalTrials.gov/show/NCT02241694 | Completed | Novo Nordisk A/S | 2015-07-31 |
| NCT02207218 | To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan | https://ClinicalTrials.gov/show/NCT02207218 | Active, not recruiting | Novo Nordisk A/S | 2021-02-04 |
| NCT02132208 | Evaluation of the TICCS Capacity to Identify Trauma Patients With Acute Coagulopathy and Massive Bleeding | https://ClinicalTrials.gov/show/NCT02132208 | Completed | Centre Hospitalier Régional de la Citadelle | 2013-06-30 |
| NCT02086682 | A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT02086682 | Completed | Mayo Clinic | 2015-08-31 |
| NCT02083549 | Evaluating URMC’s Massive Transfusion Protocol | https://ClinicalTrials.gov/show/NCT02083549 | Completed | University of Rochester | 2014-12-16 |
| NCT01312636 | Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII Deficiency | https://ClinicalTrials.gov/show/NCT01312636 | Completed | Novo Nordisk A/S | 2014-09-30 |
| NCT01285089 | Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia | https://ClinicalTrials.gov/show/NCT01285089 | Completed | Novo Nordisk A/S | 2013-10-31 |
| NCT01280825 | The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing | https://ClinicalTrials.gov/show/NCT01280825 | Recruiting | University of Chicago | 2020-11-14 |
| NCT04219371 | Reference Range Study for the Quantra QStat System | https://ClinicalTrials.gov/show/NCT04219371 | Completed | HemoSonics LLC | 2020-04-17 |
| NCT01988532 | Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia | https://ClinicalTrials.gov/show/NCT01988532 | Completed | Novo Nordisk A/S | 2014-10-31 |
| NCT01959555 | Project to Update the Study of Congenital Haemophilia in Spain | https://ClinicalTrials.gov/show/NCT01959555 | Completed | Novo Nordisk A/S | 2014-12-31 |
| NCT01882114 | Atherosclerosis in Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT01882114 | Recruiting | University of Roma La Sapienza | 2020-12-31 |
| NCT01876745 | A Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann’s Thrombasthenia in Japan | https://ClinicalTrials.gov/show/NCT01876745 | Completed | Novo Nordisk A/S | 2017-06-01 |
| NCT01862367 | Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study | https://ClinicalTrials.gov/show/NCT01862367 | Completed | Novo Nordisk A/S | 2019-06-26 |
| NCT01779921 | Treatment of Congenital Factor VII Deficiency | https://ClinicalTrials.gov/show/NCT01779921 | Completed | Novo Nordisk A/S | 2012-01-31 |
| NCT01727830 | Hemodilution and Coagulopathy With 3 Colloids | https://ClinicalTrials.gov/show/NCT01727830 | Completed | University of Zurich | 2012-11-30 |
| NCT04356950 | Analysis of the Coagulopathy Developed by COVID-19 Infected Patients | https://ClinicalTrials.gov/show/NCT04356950 | Recruiting | Centre Hospitalier Universitaire de NÄ«mes | 2020-10-31 |
| NCT01638481 | Chronology of Occult and Gross Coagulopathy in Burn Patients | https://ClinicalTrials.gov/show/NCT01638481 | Active, not recruiting | Medstar Health Research Institute | 2017-03-31 |
| NCT01589172 | Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury | https://ClinicalTrials.gov/show/NCT01589172 | Completed | University of California, San Diego | 2012-11-30 |
| NCT01586936 | Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors | https://ClinicalTrials.gov/show/NCT01586936 | Completed | Novo Nordisk A/S | 2010-03-09 |
| NCT01579968 | Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery | https://ClinicalTrials.gov/show/NCT01579968 | Completed | Novo Nordisk A/S | 2010-03-09 |
| NCT01579955 | Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice | https://ClinicalTrials.gov/show/NCT01579955 | Completed | Novo Nordisk A/S | 2010-03-09 |
| NCT01503567 | Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries | https://ClinicalTrials.gov/show/NCT01503567 | Completed | Novo Nordisk A/S | 2012-09-30 |
| NCT01476423 | Observational Registry of the Treatment of Glanzmann’s Thrombasthenia | https://ClinicalTrials.gov/show/NCT01476423 | Completed | Novo Nordisk A/S | 2011-10-31 |
| NCT01375725 | Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood | https://ClinicalTrials.gov/show/NCT01375725 | Completed | Universal Biosensors Pty Ltd | 2010-09-30 |
| NCT01322620 | Survey Evaluating the Psychosocial Effects of Living With Haemophilia | https://ClinicalTrials.gov/show/NCT01322620 | Completed | Novo Nordisk A/S | 2012-02-29 |
| NCT04356144 | Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections | https://ClinicalTrials.gov/show/NCT04356144 | Recruiting | Medical University of Vienna | 2020-10-01 |
| NCT04322721 | Coagulopathy on the First Postoperative Day Predicts the Long-term Survival of Traumatic Brain Injury Patients | https://ClinicalTrials.gov/show/NCT04322721 | Completed | Tang-Du Hospital | 2020-01-31 |
| NCT04274777 | The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders | https://ClinicalTrials.gov/show/NCT04274777 | Recruiting | Tang-Du Hospital | 2020-09-21 |
| NCT04269278 | Dexmedetomidine and Blood Coagulation | https://ClinicalTrials.gov/show/NCT04269278 | Recruiting | Seoul National University Bundang Hospital | 2020-12-12 |
| NCT04265508 | Assessment of Hemostatic Profile in Liver Cirrhosis | https://ClinicalTrials.gov/show/NCT04265508 | Completed | Goethe University | 2018-05-01 |
| NCT03347591 | Rare Bleeding Disorders in the Netherlands | https://ClinicalTrials.gov/show/NCT03347591 | Recruiting | Radboud University | 2020-12-01 |
| NCT04190615 | Determination of ClotPro Paediatric Reference Range Study | https://ClinicalTrials.gov/show/NCT04190615 | Recruiting | National Institute of Children’s Diseases, Slovakia | 2020-12-31 |
| NCT04159064 | Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices | https://ClinicalTrials.gov/show/NCT04159064 | Completed | AHEPA University Hospital | 2019-04-30 |
| NCT04111120 | Heparin Like Effect in Acute Variceal Bleeding | https://ClinicalTrials.gov/show/NCT04111120 | Recruiting | Postgraduate Institute of Medical Education and Research | 2020-12-31 |
| NCT04076605 | Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive Procedures | https://ClinicalTrials.gov/show/NCT04076605 | Recruiting | University of Virginia | 2020-11-01 |
| NCT03890016 | Study Comparing Modified Lee White Clotting Time Against Twenty Minute Whole Blood Clotting Test in Snakebite Victims | https://ClinicalTrials.gov/show/NCT03890016 | Recruiting | Jubilee Mission Medical College and Research Institute | 2020-05-31 |
| NCT03882593 | Blood Cell Adhesion to Arterial Filters During Cardiac Surgery | https://ClinicalTrials.gov/show/NCT03882593 | Recruiting | Instituto do Coracao | 2019-05-31 |
| NCT03876301 | Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants | https://ClinicalTrials.gov/show/NCT03876301 | Active, not recruiting | Spark Therapeutics | 2020-07-31 |
| NCT03699813 | ROTEM Versus aPTT/PT in Pediatric Surgery | https://ClinicalTrials.gov/show/NCT03699813 | Completed | University Hospital, Motol | 2018-09-15 |
| NCT03685097 | Comparison of Two Point-of-care Devices for Viscoelastic Hemostasis Assays | https://ClinicalTrials.gov/show/NCT03685097 | Completed | HemoSonics LLC | 2018-07-31 |
| NCT03572309 | Incidence of Trauma Induced Coagulopathy in Patients With Prehospital Administration of Fibrinogen | https://ClinicalTrials.gov/show/NCT03572309 | Recruiting | Masaryk University | 2020-07-31 |
| NCT03555630 | Thromboelastogram in Postdelivery Preeclamptic Patients | https://ClinicalTrials.gov/show/NCT03555630 | Completed | Augusta University | 2019-10-31 |
| NCT03555383 | Individualized Multimodal Hemostasis Evaluation Pyramid (IMHOTEP) | https://ClinicalTrials.gov/show/NCT03555383 | Recruiting | Semmelweis University | 2020-02-01 |
| NCT03482128 | Blood Transfusion and Postoperative Outcome Before and After Implementing a Coagulation Management Algorithm | https://ClinicalTrials.gov/show/NCT03482128 | Completed | Triemli Hospital | 2015-12-31 |
| NCT03475940 | Coagulopathy in Cardiac Surgery | https://ClinicalTrials.gov/show/NCT03475940 | Recruiting | Mahidol University | 2019-06-30 |
| NCT03468738 | Investigation of the Transfusion Practices in Surgical Patients in Turkey | https://ClinicalTrials.gov/show/NCT03468738 | Completed | Diskapi Teaching and Research Hospital | 2019-02-01 |
| NCT01234545 | Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors | https://ClinicalTrials.gov/show/NCT01234545 | Completed | Novo Nordisk A/S | 2012-04-30 |
| NCT01228058 | A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients | https://ClinicalTrials.gov/show/NCT01228058 | Completed | The University of Texas Health Science Center, Houston | 2012-01-31 |
| NCT01220141 | Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B | https://ClinicalTrials.gov/show/NCT01220141 | Completed | Novo Nordisk A/S | 2015-03-31 |
| NCT00998647 | Modified Ultrafiltration in Cardiac Surgery | https://ClinicalTrials.gov/show/NCT00998647 | Completed | Goethe University | 2010-04-30 |
| NCT00882778 | PROPACT: Retrospective Prophylaxis Patient Case Collection | https://ClinicalTrials.gov/show/NCT00882778 | Completed | Novo Nordisk A/S | 2010-05-31 |
| NCT00853086 | Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database | https://ClinicalTrials.gov/show/NCT00853086 | Completed | Novo Nordisk A/S | 2011-06-30 |
| NCT02568202 | Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S) | https://ClinicalTrials.gov/show/NCT02568202 | Completed | Novo Nordisk A/S | 2015-11-30 |
| NCT00969319 | Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America | https://ClinicalTrials.gov/show/NCT00969319 | Completed | Bayer | 2013-02-28 |
| NCT01830712 | A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors | https://ClinicalTrials.gov/show/NCT01830712 | Completed | Novo Nordisk A/S | 2011-08-31 |
| NCT01604083 | European Transfusion Practice and Outcome Study | https://ClinicalTrials.gov/show/NCT01604083 | Completed | European Society of Anaesthesiology | 2013-10-31 |
| NCT04267406 | ADAMTS-13 and Von Willebrand Factor Levels and Activities in Children With Cirrhosis and/or Portal Hypertension | https://ClinicalTrials.gov/show/NCT04267406 | Completed | Ataturk University | 2019-10-30 |
| NCT03391622 | Thrombin Generation Values and Percutaneous Coronary Intervention Results. | https://ClinicalTrials.gov/show/NCT03391622 | Recruiting | HaEmek Medical Center, Israel | 2019-08-30 |
| NCT04107818 | Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients. | https://ClinicalTrials.gov/show/NCT04107818 | Recruiting | Masaryk University | 2020-08-01 |
| NCT03674684 | ROTEM Assessment of Modern Crystalloid, Hydroxyethyl Starch and Gelatin Effect on Coagulation | https://ClinicalTrials.gov/show/NCT03674684 | Completed | University Hospital, Motol | 2018-07-14 |
| NCT00782470 | Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A | https://ClinicalTrials.gov/show/NCT00782470 | Completed | Bayer | 2010-11-30 |
| NCT00772434 | Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument | https://ClinicalTrials.gov/show/NCT00772434 | Completed | Rockefeller University | 2011-05-31 |
| NCT00710619 | Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX | https://ClinicalTrials.gov/show/NCT00710619 | Completed | Novo Nordisk A/S | 2009-07-31 |
| NCT00703911 | Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors | https://ClinicalTrials.gov/show/NCT00703911 | Completed | Novo Nordisk A/S | 2010-07-31 |
| NCT00697320 | Observational Study on the Efficacy and Safety of NovoSeven® During “Real-life” Usage in Germany | https://ClinicalTrials.gov/show/NCT00697320 | Completed | Novo Nordisk A/S | 2010-12-31 |
| NCT00522002 | CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study | https://ClinicalTrials.gov/show/NCT00522002 | Completed | George Washington University | 2010-06-30 |
| NCT00516126 | Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery | https://ClinicalTrials.gov/show/NCT00516126 | Completed | University Hospital, Basel, Switzerland | 2011-12-31 |
| NCT00210197 | Hypercoagulability After Breast Cancer Surgery | https://ClinicalTrials.gov/show/NCT00210197 | Completed | Institut Bergonié | NA |
| NCT00165906 | Thrombin Generation in Neonates | https://ClinicalTrials.gov/show/NCT00165906 | Completed | Emory University | 2009-01-31 |
| NCT00124293 | Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury | https://ClinicalTrials.gov/show/NCT00124293 | Completed | Novo Nordisk A/S | 2005-11-23 |
| NCT00091494 | Socioeconomic Patterning of Inflammation and Hemostasis - Ancillary to MESA | https://ClinicalTrials.gov/show/NCT00091494 | Completed | University of Michigan | 2008-06-30 |
| NCT00086476 | Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles | https://ClinicalTrials.gov/show/NCT00086476 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00063518 | Monitoring Trends in Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00063518 | Completed | University of Massachusetts, Worcester | 2007-12-31 |
| NCT00005481 | Epidemiology of Impaired Coagulant Balance in Diabetes | https://ClinicalTrials.gov/show/NCT00005481 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | NA |
| NCT00001927 | Study of Abnormal Blood Clotting in Children With Stroke | https://ClinicalTrials.gov/show/NCT00001927 | Completed | National Institutes of Health Clinical Center (CC) | NA |
#If less then 500 registries
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT03255928 | Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD) | https://ClinicalTrials.gov/show/NCT03255928 | Recruiting | Scientific Institute San Raffaele | 2020-06-29 |
| NCT02813538 | Major Liver Resection: Early Clotting Disorders and Functional Impairment. | https://ClinicalTrials.gov/show/NCT02813538 | Completed | Hospital General Universitario Gregorio Marañon | 2018-10-31 |
| NCT02776826 | World Bleeding Disorders Registry Pilot Study | https://ClinicalTrials.gov/show/NCT02776826 | Completed | World Federation of Hemophilia | 2016-12-31 |
| NCT02720679 | Investigation of the Genetics of Hematologic Diseases | https://ClinicalTrials.gov/show/NCT02720679 | Recruiting | St. Jude Children’s Research Hospital | 2026-08-31 |
| NCT02512250 | Swiss Hemophilia Registry | https://ClinicalTrials.gov/show/NCT02512250 | Recruiting | Swiss Hemophilia Network | 2025-12-31 |
| NCT04329390 | MAC Project, Monitoring of AntiCoagulant Therapies (MAC) | https://ClinicalTrials.gov/show/NCT04329390 | Recruiting | Quovadis Associazione | 2024-03-01 |
| NCT04201860 | Blood Gas and Bleeding Disorders in Healthy Volunteers Exposed to Nitroglycerin and Nitrogen Compounds | https://ClinicalTrials.gov/show/NCT04201860 | Completed | San Salvatore Hospital of L’Aquila | 2018-11-12 |
| NCT03956836 | Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC) | https://ClinicalTrials.gov/show/NCT03956836 | Recruiting | Hospitales Universitarios Virgen del RocÃo | 2020-10-31 |
| NCT03834727 | Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders | https://ClinicalTrials.gov/show/NCT03834727 | Enrolling by invitation | Oregon Health and Science University | 2021-09-04 |
| NCT03647644 | Coagulation Test Changes Associated With Acute Normovolemic Hemodilution in Cardiac Surgery | https://ClinicalTrials.gov/show/NCT03647644 | Completed | Mayo Clinic | 2018-10-11 |
| NCT02279199 | Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM) | https://ClinicalTrials.gov/show/NCT02279199 | Active, not recruiting | Oregon Health and Science University | 2022-01-31 |
| NCT03760874 | Atrial Fibrillation Research Database | https://ClinicalTrials.gov/show/NCT03760874 | Recruiting | University of Campania “Luigi Vanvitelli” | 2022-01-01 |